1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
The fund's Board of Trustees approved a transferable rights offering that lets common shareholders buy new common shares at a discount to market price, subject to a sales load. The fund says the proceeds would add capital for infrastructure investments while reducing the need to sell existing holdings.
Record date is September 21, 2026; each common share held earns one transferable right.
Three rights are needed to subscribe for one new common share; the subscription price is 92.5% of the average closing price or 92.5% of NAV, whichever is lower.
Subscription period runs to October 15, 2026; rights are expected to trade on the NYSE under ASGI RT beginning about September 22, 2026.
Shares issued in the offering will not receive the September 30, 2026 distribution or the October distribution.
Fly-E Group's Chief Executive Officer and Director, Lisa Fan, resigned effective immediately on September 11, 2026, and the filing states the resignation was not due to any disagreement with the company or its board. The board appointed Qiang Chen as CEO and Jingxia Song as an independent director, both effective immediately, which changes the company's top executive and board composition.
Lisa Fan resigned as CEO and Director effective September 11, 2026; the filing says there was no disagreement on any matter
Qiang Chen, 54, appointed CEO; he was previously chief financial officer of General Steel Holdings, Inc. from May 2004 to December 2015
Chen's employment agreement sets annual compensation at $60,000
Jingxia Song, 40, appointed independent Director and member of the Audit, Nominating and Corporate Governance, and Compensation committees; her offer letter sets annual compensation at $26,400
Coty said CFO Laurent Mercier stopped serving as Chief Financial Officer on September 1, 2026, in connection with the previously announced appointment of Soraya Benchikh as CFO. He will serve as Strategic CEO Advisor under a Transition Agreement through June 30, 2027, with pay and benefit terms that the filing details.
Mercier ceased being CFO on September 1, 2026; Soraya Benchikh was previously announced as successor
Mercier keeps a €825,000 annual base salary through June 30, 2027 for advisory services and will be released from active duties beginning November 1, 2026
He will receive a fixed one-time bonus of €290,000 and no annual bonus or variable pay for fiscal 2026 or 2027
At its September 8, 2026 annual meeting, Toppoint Holdings stockholders approved a reverse stock split of 1-for-2 to 1-for-900 at the Board's discretion, a reincorporation from Nevada to Delaware, and an increase in authorized common stock from 300,000,000 to 1,000,000,000 shares. Five directors were also elected. Neither the reincorporation nor the share increase has taken effect yet, so the votes authorize future changes that shareholders will be notified of separately.
Reverse split authority: 15,657,330 votes for and 55,377 against, usable through August 24, 2029, at ratios from 1-for-2 to 1-for-900.
Authorized common shares to rise from 300,000,000 to 1,000,000,000; approved with 15,619,194 for and 93,512 against.
Reincorporation to Delaware approved with 14,757,565 for, 16,707 against and 938,422 broker non-votes.
Five directors elected, including Anthony Kwong, Chung Ming Bruce Hui and Christy Tarala; Jimmy M. Wong's term ended and he was not renominated.
On September 9, 2026, Centrus Energy priced an underwritten offering of Class A common stock, pre-funded warrants and common warrants, with gross proceeds expected to be about $500 million before underwriting discount and expenses. Closing is expected on or about September 11, 2026, and the company said proceeds may fund working capital, technology, debt repayment, capital expenditures and acquisitions. The filing also discloses advanced talks on a potential acquisition of a domestic manufacturing supplier for about $115 million to $125 million, but no definitive agreement has been signed, and the new warrants could dilute existing shareholders if exercised.
Offering of 500,000 Class A shares, pre-funded warrants for 2,005,513 shares and common warrants for up to 6,992,382 shares, priced at a combined $199.64 per share
Gross proceeds expected to be about $500 million, before underwriting discount and other offering expenses; closing expected on or about September 11, 2026
Common warrants have four exercise price series from $226.8625 to $362.9800 per share
Company is in advanced discussions on a potential acquisition priced at about $115 million to $125 million; target generated about $160 million of revenue in 2025, and no definitive agreement has been signed
Oportun Financial appointed William Franklin, formerly CFO of Consumer Banking at Discover Financial Services, as its Chief Financial Officer effective September 8, 2026. Joseph Schueller, the Controller, will no longer serve as principal financial officer but remains in his current role. The filing describes the change in leadership of the finance function without reporting any financial results.
William Franklin, 48, was named CFO and principal financial officer effective September 8, 2026, succeeding Joseph Schueller in that role.
Franklin's offer letter provides a $500,000 base salary, a 2026 target bonus of 75% of base salary, and a $200,000 signing bonus vesting on the six-month anniversary of the effective date.
Franklin is to receive a 276,626 RSU new hire award, expected to be granted in December 2026, subject to Board approval and continued employment.
AMREP Corporation reported net income of $276,000, or $0.05 per diluted share, for the fiscal first quarter ended July 31, 2026, down from $4,692,000, or $0.87 per diluted share, a year earlier. Revenues fell to $6.1 million from $17.9 million, and shareholders also approved a 2026 Equity Compensation Plan at the September 10 annual meeting.
Net income: $276,000 ($0.05 per diluted share) vs. $4,692,000 ($0.87) in the same quarter last year
Revenues: $6,051,000 vs. $17,851,000 a year earlier
Shareholders approved the 2026 Equity Compensation Plan, which allows up to 500,000 shares and becomes effective September 20, 2026
Directors Timothy S. McNaney and Albert V. Russo were re-elected to terms ending at the 2029 annual meeting
Peraso's chief financial officer, James Sullivan, resigned for personal reasons, effective October 2, 2026, and the filing says the resignation was not due to any disagreement with the company. CEO Ronald Glibbery will also serve as interim CFO and principal financial officer without additional pay, and stockholders on September 10, 2026 approved adding 1,500,000 shares to the company's 2019 stock incentive plan.
James Sullivan resigns as CFO and Secretary effective October 2, 2026, citing personal reasons
Ronald Glibbery, CEO and board member, becomes interim CFO and Secretary effective October 2, 2026, with no added compensation
Stockholders approved 1,500,000 additional shares for the 2019 Stock Incentive Plan at the September 10, 2026 annual meeting
On September 8, 2026, P3 Health Partners entered a Securities Purchase Agreement with affiliates of CPF to issue up to $70 million of units in multiple tranches, each including Series D-1 19.5% Cumulative Preferred Stock and warrants. A special committee of independent directors approved the deal because the CPF affiliates may be related parties. The preferred stock ranks senior to common stock, and the warrants could add to the number of common shares outstanding.
Up to $70 million of units to be issued in multiple tranches under a Securities Purchase Agreement dated September 8, 2026.
Series D-1 preferred stock: 19.5% cumulative dividend, $100 stated value per share, not convertible, no voting rights, redeemable at $100 per share plus unpaid dividends.
Warrants exercisable for 0.66333% of outstanding Class A and Class V common stock per $1,000,000 funded, with a seven-year term.
CPF may designate one additional independent director while it owns 40% of common stock; the 49.99% standstill limit is extended from January 1, 2027 to December 31, 2027.
Korsana Biosciences completed its merger with Cyclerion Therapeutics on September 8, 2026, and the combined company is set to trade on Nasdaq under the ticker KRSA starting September 9. The closing included a $380 million private placement and a 1-for-7 reverse split of Cyclerion common stock, leaving about 55.1 million shares and share equivalents outstanding, excluding equity awards. The company expects pro-forma cash of about $475 million to fund operations into 2029, but it reported a $30.9 million net loss for the six months ended June 30, 2026.
Merger closed September 8, 2026; shares begin trading on Nasdaq as KRSA on September 9, 2026
$380 million gross proceeds from a private placement led by Fairmount and Venrock Healthcare Capital Partners
About 55.1 million shares and share equivalents outstanding after closing, excluding equity awards
Pro-forma cash of about $475 million, expected to fund operations into 2029; net loss of $30.9 million for the six months ended June 30, 2026
Stephen M. Silver resigned as chief executive officer, chair and director of M Evo Global Acquisition Corp II, effective immediately, on September 9, 2026, and the filing says the resignation was not due to any disagreement with the company. The board appointed Chief Operating Officer Ashley Zumwalt-Forbes as CEO and chair, and the board may fill the resulting board vacancy. The filing says the company is a special purpose acquisition company and does not describe any change to its operations or financial results.
Stephen M. Silver resigned as CEO, Chairman and director effective immediately; notice given September 9, 2026
Ashley Zumwalt-Forbes, age 36, appointed CEO and elected Chair, effective concurrently with Silver's resignation
Zumwalt-Forbes remains Chief Operating Officer and a board member; she is a managing member of the sponsor, Evolution Sponsor Holdings LLC II
No new or modified compensation arrangement has been entered into as of the filing date
UniFirst said Executive Vice President and Chief Operating Officer Kelly Rooney resigned to pursue other career opportunities, with her final day of employment on September 11, 2026. The company entered into a Separation Agreement and General Release with her that day, and she will not receive severance-related payments or benefits because she resigned voluntarily.
Kelly Rooney resigned as Executive Vice President and Chief Operating Officer; final day is September 11, 2026
Separation Agreement and General Release signed September 11, 2026, including a general release of claims and a cooperation obligation
No severance-related payments or benefits due because the departure was voluntary
The filing does not name a successor or interim COO
Fractyl Health said Nasdaq notified it on September 10, 2026 that its stock is subject to delisting because it did not regain compliance with the $1.00 minimum bid price requirement by September 9, 2026. The company intends to request a hearing before a Nasdaq Hearings Panel, which would keep its stock listed while the process runs, and has proposed a reverse stock split of 1-for-5 to 1-for-15 for stockholder approval.
Nasdaq letter dated September 10, 2026 says the stock is subject to delisting unless the company timely requests a hearing
Company did not meet the $1.00 minimum bid price within the 180-calendar day grace period ending September 9, 2026
Company intends to request a Panel hearing, which automatically stays suspension or delisting
Proxy statement filed August 24, 2026 seeks approval for a reverse split ranging from 1-for-5 to 1-for-15
Skye Bioscience's Chief Financial Officer John P. Sharp resigned effective September 8, 2026, and CEO Punit Dhillon was appointed principal financial and accounting officer. The company also gave notice to end its Master Services Agreement with Lohman & Associates on the same date, and Nasdaq confirmed the company regained compliance with the minimum bid price rule. The filing states Sharp's departure was not due to any disagreement with the auditors or the company on financial or operating matters.
Sharp resigned as CFO and principal financial and accounting officer effective September 8, 2026; the filing says there was no disagreement with auditors or the company on financial statements, internal controls, operations, policies or pra
Board appointed CEO Punit Dhillon as principal financial and accounting officer effective September 8, 2026; his employment terms are unchanged.
Company terminated the Master Services Agreement dated March 31, 2026 with Lohman & Associates, Inc., effective September 8, 2026.
Nasdaq letter received September 8, 2026 confirmed a closing bid price at or above $1.00 for 10 consecutive business days (August 24 through September 4, 2026), closing the matter.
On September 8, 2026, Net Power and its affiliates entered three agreements with Baker Hughes affiliates that indefinitely suspend the utility-scale oxy-combustion development and commercialization arrangements. The filing says no royalty has been agreed and none is assured, and no party is obligated to deploy a plant, so shareholders face a narrower path to near-term revenue from this partnership.
Effective September 8, 2026, the A&R JDA and Commercial Agreement are suspended indefinitely; the filing says neither agreement is terminated.
Baker Hughes' access and exclusivity rights at the La Porte, Texas demonstration facility terminated on the Suspension Date.
The license amendment, effective January 1, 2026, keeps NP's utility-scale exclusive license but sets up industrial-scale licensing with a royalty that has not been agreed.
The filing states the suspension did not arise from any breach or default, and that Net Power determined utility-scale commercialization was not economical at this time.
On September 11, 2026, Caring Brands completed an additional closing of its private placement of Series B Convertible Preferred Stock, raising $2,549,900 in gross proceeds and bringing the offering total to $7,149,900. The company says pro forma stockholders' equity of $8,220,419 as of August 31, 2026 is above the $2,500,000 Nasdaq minimum, but the figures are preliminary and unaudited, and Nasdaq has not confirmed compliance.
Subsequent closing on September 11, 2026 added $2,549,900 in gross proceeds; total offering proceeds are $7,149,900.
Preferred shares from the closing are initially convertible into 3,642,714 common shares at $0.70 per share, subject to a 19.99% exchange cap.
Pro forma stockholders' equity is $8,220,419 versus a historical deficit of $2,632,167 at August 31, 2026, against a Nasdaq minimum of $2,500,000.
Nasdaq has not confirmed compliance; the company has asked the Nasdaq Hearings Panel to resolve the deficiency after a July 15, 2026 delisting determination.
Digital Brands Group updated investors on a go-private review and on its U.S. Program contract. The board is evaluating an existing shareholder's proposal to acquire all outstanding common stock for $77.58 per share in cash, and a 60-day go-shop period ends October 5, 2026. The filing does not state a definitive agreement, so shareholders have no completed transaction terms yet.
Proposal from an existing shareholder with a net worth above $1 billion: $77.58 per share in cash for all outstanding common stock
Go-shop period of 60 days ends October 5, 2026; Roth Capital Partners is the financial advisor
U.S. Program: two-year, $165 million binding contract; $3.3 million guaranteed cash flow from September 1 to December 31, 2026
Company forecasts a 15% to 18% cash flow margin for the U.S. Program and projects $25 million to $35 million in cash flow over the next 24 months
ChampionsGate Acquisition Corp, a special purpose acquisition company listed on Nasdaq, announced on September 11, 2026 that it entered into a business combination agreement with Futuremain Co., Ltd., a South Korean machinery safety diagnostics company. The transaction would make Futuremain an indirect wholly owned subsidiary of a new publicly listed company, Pubco, and is expected to close in 2027, subject to shareholder and regulatory approvals.
Futuremain's estimated enterprise value is $80 million, and Pubco shares are valued at $10.00 each for the exchange consideration.
The transaction is expected to close in 2027, subject to regulatory approvals, shareholder approvals of both companies, and other customary closing conditions.
Pubco is expected to be a Cayman Islands exempted company listed on the Nasdaq Stock Market.
FocalPoint Asia is acting as exclusive financial advisor to Futuremain.
On September 11, 2026, New Fortress Energy completed a restructuring of its principal funded debt under UK Restructuring Plans. The Brazil business was separated into BrazilCo, and about $5.7 billion of third-party debt was exchanged for new equity, term loans and preferred equity, with plan creditors receiving 65% of CoreCo common stock. Existing stockholders keep 35% of CoreCo common stock, and the new structure adds preferred equity and new debt ahead of common shareholders.
Terminated debt exchanged for 65% of CoreCo common stock, with existing stockholders retaining 35%
CoreCo issued 2,454,936 Series A Mandatorily Convertible Preferred shares; the press release cites $2.45 billion of liquidation preference
$571.3 million in New CoreCo Take-Back Term Loans plus $136.5 million of new financing raised from existing creditors
Chief Executive Officer Wesley R. Edens received CoreCo shares and preferred stock under the Term Loan A exchange and purchased additional shares on the Closing Date for $1,667,985.02
Coffee Holding Co. reported results for the quarter ended July 31, 2026. Net sales fell 9.3% to $21,686,262 as lower green coffee prices led to price cuts and promotions, but net income was $1,993,438, or $0.35 per share, compared with a net loss of $1,205,413, or $0.21 per share, a year earlier. Management attributed much of the profit gain to a favorable inventory position, tariff refunds and a net trading gain, and said it expects more tariff refunds to add to earnings over the next two quarters.
Net sales were $21,686,262, down $2,224,252 or 9.3% from $23,910,514 a year earlier.
Net income was $1,993,438 ($0.35 per share) versus a net loss of $1,205,413 ($0.21 per share) in the prior-year quarter.
Gross profit rose to $5,424,131, or 25.0% of net sales, from 9.4% a year earlier.
Tariff refunds received in the quarter contributed approximately $0.06 per share to earnings.
Boston Omaha's Board approved a new program to repurchase up to $30 million of Class A common stock, effective November 1, 2026, replacing the 2025 program. The company had already bought back 1,607,323 shares for about $21 million under the 2025 plan through September 10, 2026, and plans to fund the new program from available cash.
New program authorizes up to $30 million of Class A common stock repurchases, effective November 1, 2026
Program expires on the earlier of December 31, 2027 or when $30 million has been repurchased
Under the 2025 plan, the company repurchased 1,607,323 shares for about $21 million through September 10, 2026
Company is not obligated to repurchase any specific number of shares and may modify, suspend or terminate the program
Kroger reported second-quarter 2026 sales of $34.6 billion, up from $33.9 billion a year earlier, and GAAP earnings of $1.05 per diluted share versus $0.91. The company kept its full-year 2026 adjusted EPS guidance of $5.10 to $5.30 but lowered its identical sales without fuel guidance to 0.2% to 0.8% from 1.0% to 2.0%, and adjusted FIFO operating profit fell slightly year over year.
Q2 2026 adjusted EPS was $1.09 versus $1.04 a year earlier; adjusted FIFO operating profit was $1,076 million versus $1,091 million.
Identical sales without fuel rose 0.2% in the quarter, compared with 3.4% a year earlier.
Full-year 2026 adjusted EPS guidance of $5.10 to $5.30 was reaffirmed; identical sales guidance was cut to 0.2% to 0.8%.
Kroger repurchased $1.0 billion of shares in the quarter, with about $800 million left on the $2 billion authorization, and will host an investor update on October 20, 2026.
Citi Trends said its Executive Vice President, Chief Financial Officer and Chief Accounting Officer, Heather Plutino, will step down for personal reasons. She will stay in her role while the company searches for a successor, and the company said the departure does not involve any dispute with the company or its board.
Heather Plutino notified the company on September 10, 2026 of her decision to step down.
She will remain in her current role while the company searches for her successor.
The filing says the departure is not due to any dispute or disagreement over company operations, policies or practices.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.